Hinge Health Insider James Pursley Files for Proposed Share Sale

TL;DR

**Insider James Pursley is planning to sell Hinge Health shares.**

AI Summary

James Pursley, an insider, has filed a Form 144 indicating a proposed sale of securities in Hinge Health, Inc. (CIK: 0001673743). This filing, dated March 23, 2026, signals that an insider intends to sell shares, which could be interpreted by investors as a lack of confidence in the company's future growth or simply a diversification of personal assets. For current or prospective shareholders, this matters because significant insider selling can sometimes precede a decline in stock price if other investors interpret it negatively.

Why It Matters

Insider selling can sometimes signal to the market that those with the most intimate knowledge of a company believe its stock may be overvalued or that better opportunities exist elsewhere, potentially influencing investor sentiment and stock price.

Risk Assessment

Risk Level: medium — Insider selling, while not always negative, can introduce uncertainty and potentially put downward pressure on a stock's price.

Analyst Insight

An investor should monitor subsequent filings (like Form 4) to confirm the actual sale and its size, and consider this alongside Hinge Health's financial performance and market conditions before making investment decisions.

Key Players & Entities

• Pursley James (person) — Reporting individual proposing to sell securities
• Hinge Health, Inc. (company) — Subject company whose securities are being proposed for sale
• 0001783108 (person) — CIK of James Pursley
• 0001673743 (company) — CIK of Hinge Health, Inc.
• 2026-03-23 (date) — Filing Date

FAQ

Filing Documents

• primary_doc.html (144)
• primary_doc.xml (144) — 4KB
• 0001950047-26-002905.txt ( ) — 6KB

From the Filing

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 FORM 144 144: Filer Information Is this a LIVE or TEST Filing? LIVE TEST Submission Contact Information Name Phone E-Mail Address 144: Issuer Information Name of Issuer Hinge Health, Inc. Address of Issuer 455 Market Street, Suite 700 San Francisco CALIFORNIA 94105 Phone 4157262206 Name of Person for Whose Account the Securities are To Be Sold JAMES PURSLEY See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. Relationship to Issuer Officer 144: Securities Information Title of the Class of Securities To Be Sold Name and Address of the Broker Number of Shares or Other Units To Be Sold Aggregate Market Value Number of Shares or Other Units Outstanding Approximate Date of Sale Name the Securities Exchange Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York � NY � 10004 15000 637200.00 55816216 03/23/2026 NYSE Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor: 144: Securities To Be Sold Title of the Class Date you Acquired Nature of Acquisition Transaction Name of Person from Whom Acquired Is this a Gift? Date Donor Acquired Amount of Securities Acquired Date of Payment Nature of Payment * Common 04/01/2023 Performance Stock Units Issuer 15000 04/01/2023 N/A * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid. Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold. 144: Securities Sold During The Past 3 Months Name and Address of Seller Title of Securities Sold Date of Sale Amount of Securities Sold Gross Proceeds 10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco � CA � 94105 Common 02/23/2026 15000 589983.00 144: Remarks and Signature Remarks The securities to be sold were acquired upon the vesting of performance stock units during the period of 4/1/2023 through 3/31/2025. Date of Notice 03/23/2026 Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1 06/13/2025 ATTENTION: The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. Signature /s/ James Pursley ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

View Full Filing

View this 144 filing on SEC EDGAR